✉ Email this page to a colleague
« Back to Dashboard
Puerarin is an investigational drug.
There have been 7 clinical trials for Puerarin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Arthritis, and Rheumatic Diseases. The leading clinical trial sponsors are Chengdu PLA General Hospital, Cairo University, and Health and Medical Research Fund.
There are forty-four US patents protecting this investigational drug and nine hundred and three international patents.
Recent Clinical Trials for Puerarin
|Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia||Jiangxi University of Traditional Chinese Medicine||N/A|
|Effect of Puerarin on Heart Health in Men||Health and Medical Research Fund||Phase 2|
|Effect of Puerarin on Heart Health in Men||Health and Medical Research Fund, Hong Kong||Phase 2|
Top disease conditions for Puerarin
Top clinical trial sponsors for Puerarin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Puerarin||⤷ Try a Trial||Fire extinguishing composition comprising aldoketones compound||XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (Xi'An Shaanxi, CN)||⤷ Try a Trial|
|Puerarin||⤷ Try a Trial||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||⤷ Try a Trial|
|Puerarin||⤷ Try a Trial||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||⤷ Try a Trial|
|Puerarin||⤷ Try a Trial||Glycan therapeutics and related methods thereof||KALEIDO BIOSCIENCES, INC. (Lexington, MA)||⤷ Try a Trial|
|Puerarin||⤷ Try a Trial||Compartmented pharmaceutical dosage forms||Triastek, Inc. (Nanjing, CN)||⤷ Try a Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Puerarin||China||CN102648751||2032-05-02||⤷ Try a Trial|
|Puerarin||Japan||JP2015517298||2032-05-02||⤷ Try a Trial|
|Puerarin||Japan||JP5957600||2032-05-02||⤷ Try a Trial|
|Puerarin||World Intellectual Property Organization (WIPO)||WO2013163940||2032-05-02||⤷ Try a Trial|
|Puerarin||China||CN106029628||2034-04-16||⤷ Try a Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|